デフォルト表紙
市場調査レポート
商品コード
1019668

細胞および遺伝子治療製造の市場動向・市場シェア・市場規模の予測 (2021-2028年):治療タイプ・スケール (R&D・商業製造)・製造モード・ワークフロー (ベクター製造・セルバンキング)・地域別

Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Therapy Type, By Scale (R&D, Commercial), By Mode, By Workflow (Vector Production, Cell Banking), By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 188 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
細胞および遺伝子治療製造の市場動向・市場シェア・市場規模の予測 (2021-2028年):治療タイプ・スケール (R&D・商業製造)・製造モード・ワークフロー (ベクター製造・セルバンキング)・地域別
出版日: 2021年07月07日
発行: Grand View Research, Inc.
ページ情報: 英文 188 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞および遺伝子治療薬製造の市場規模は予測期間中20.3%のCAGRで推移し、2028年には574億米ドルの規模に成長すると予測されています。

臨床パイプラインの急激な増加や、先進的な治療法に対する規制当局の承認の増加などの要因が同市場の成長を推進しています。

当レポートでは、世界の細胞および遺伝子治療薬製造の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、治療タイプ・スケール・製造モード・ワークフロー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の分類
  • 親市場
  • 付随市場
  • 市場力学
  • SWOT分析
  • ポーターのファイブフォース分析
  • 主要な取引・戦略的提携
  • COVID-19:影響分析

第4章 競合分析

  • 主要企業・近年の展開・影響分析
  • 企業マッピング
  • 潜在的エンドユーザーのリスト
  • 新興企業のリスト
  • 市場の差別化要因
  • 競合ダッシュボード分析
  • 地域ネットワークマップ

第5章 市場分析・予測:治療タイプ別

  • 細胞治療薬製造
  • 遺伝子治療薬製造

第6章 市場分析・予測:スケール別

  • 前商業・R&D
  • 商業スケール

第7章 市場分析・予測:モード別

  • 受託製造
  • 社内製造

第8章 市場分析・予測:ワークフロー別

  • 細胞処理
  • セルバンキング
  • プロセス開発
  • フィル&フィニッシュ
  • 分析・品質検査
  • 原材料検査
  • ベクター製造
  • その他

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

  • 戦略的枠組み
  • 参入事業者の分類
  • 企業プロファイル
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 CMO Investments in API Biologics - Cell, Gene, Vaccine, and Virus, April-July 2020
  • Table 3 FDA approved Cellular and Gene Therapy Products as of July 2020
  • Table 4 Cell and Gene Therapy Products approved in the European Union
  • Table 5 Summary of risk factors associated with COVID-19 transmission in cell and gene therapy manufacturing
  • Table 6 Impact Analysis
  • Table 7 List of cell therapy manufacturers:
  • Table 8 List of potential end-users
  • Table 9 List of emerging players
  • Table 10 List of market differentiators
  • Table 11 Competitive dashboard analysis
  • Table 12 Regional network map
  • Table 13 Top cell therapy companies of 2020
  • Table 14 Testing methods
  • Table 15 Best Practices for the effective control of raw material
  • Table 16 Operating CMOs/ CDMOs for cell and gene therapy manufacturing in the North America
  • Table 17 Cell and Gene Therapy Manufacturing Capacity in North America as of 2018
  • Table 18 Operating CMOs/ CDMOs for cell and gene therapy manufacturing in the EU
  • Table 19 Cell & Gene Therapy Manufacturing Capacities in Europe 2017
  • Table 20 Distribution of cleanroom footprint, and QC footprint across the U.K.
  • Table 21 Aggregated total number of cellular therapy product manufacturing facilities, GMP laboratories, manufacturing and quality staff, parallel processes and projects by country and state/region.
  • Table 22 Noteworthy regenerative medicine CMOs in operation in Japan
  • Table 23 North America cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 24 North America cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 25 North America cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 26 North America cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 27 North America cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 28 U.S. cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 29 U.S. cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 30 U.S. cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 31 U.S. cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 32 U.S. cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 33 Canada cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 34 Canada cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 35 Canada cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 36 Canada cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 37 Canada cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 38 Europe cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 39 Europe cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 40 Europe cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 41 Europe cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 42 Europe cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 43 Germany cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 44 Germany cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 45 Germany cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 46 Germany cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 47 Germany cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 48 U.K. cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 49 U.K. cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 50 U.K. cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 51 U.K. cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 52 U.K. cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 53 Italy cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 54 Italy cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 55 Italy cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 56 Italy cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 57 Italy cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 58 France cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 59 France cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 60 France cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 61 France cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 62 France cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 63 Spain cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 64 Spain cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 65 Spain cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 66 Spain cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 67 Spain cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 68 Asia Pacific cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 69 Asia Pacific cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 70 Asia Pacific cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 71 Asia Pacific cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 72 Asia Pacific cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 73 Japan cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 74 Japan cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 75 Japan cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 76 Japan cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 77 Japan cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 78 China cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 79 China cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 80 China cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 81 China cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 82 China cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 83 India cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 84 India cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 85 India cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 86 India cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 87 India cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 88 South Korea cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 89 South Korea cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 90 South Korea cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 91 South Korea cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 92 South Korea cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 93 Latin America cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 94 Latin America cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 95 Latin America cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 96 Latin America cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 97 Latin America cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 98 Brazil cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 99 Brazil cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 100 Brazil cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 101 Brazil cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 102 Brazil cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 103 Mexico cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 104 Mexico cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 105 Mexico cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 106 Mexico cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 107 Mexico cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 108 MEA cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 109 MEA cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 110 MEA cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 111 MEA cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 112 MEA cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 113 South Africa cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 114 South Africa cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 115 South Africa cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 116 South Africa cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 117 South Africa cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)
  • Table 118 Saudi Arabia cell & gene therapy manufacturing market, by therapy type, 2017 - 2028 (USD Million)
  • Table 119 Saudi Arabia cell therapy manufacturing market, by cell type, 2017 - 2028 (USD Million)
  • Table 120 Saudi Arabia cell & gene therapy manufacturing market, by scale, 2017 - 2028 (USD Million)
  • Table 121 Saudi Arabia cell & gene therapy manufacturing market, by mode, 2017 - 2028 (USD Million)
  • Table 122 Saudi Arabia cell & gene therapy manufacturing market, by workflow, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Medicines in development by disease
  • Fig. 9 Classification of companies
  • Fig. 10 Cell and gene therapy manufacturing market snapshot, 2020 (USD Million)
  • Fig. 11 Cell &gene therapy manufacturing market segmentation
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Gene therapy clinical trials number as of 2019
  • Fig. 14 Regenerative medicine clinical trials
  • Fig. 15 Expedited approval pathway designations by technology
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Market opportunity relevance analysis (Current & future impact)
  • Fig. 18 Cell and gene therapy market SWOT analysis
  • Fig. 19 Cell and gene therapy market Porter's five forces analysis
  • Fig. 20 Cell therapy manufacturing collaborations from 2014 to 2018
  • Fig. 21 Areas of disruption due to COVID-19 reported by respondents
  • Fig. 22 Cell and gene therapy market: Therapy type outlook and key takeaways
  • Fig. 23 Cell and gene therapy market: Therapy type movement analysis
  • Fig. 24 Cell therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 25 Cell therapy manufacturing market estimates and forecast for stem cell therapy, 2017 - 2028 (USD Million)
  • Fig. 26 Cell therapy manufacturing market estimates and forecast for non-stem cell therapy, 2017 - 2028 (USD Million)
  • Fig. 27 Gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 28 Cell and gene therapy Manufacturing market: Scale outlook and key takeaways
  • Fig. 29 Cell and gene therapy Manufacturing market: Scale movement analysis
  • Fig. 30 Cell and gene therapy manufacturing market estimates and forecast for pre-commercial scale manufacturing, 2017 - 2028 (USD Million)
  • Fig. 31 Cell and gene therapy Manufacturing) market estimates and forecast for commercial scale manufacturing, 2017 - 2028 (USD Million)
  • Fig. 32 Cell and gene therapy manufacturing market: Mode outlook and key takeaways
  • Fig. 33 Cell and gene therapy manufacturing market: Mode movement analysis
  • Fig. 34 Cell and gene therapy manufacturing market for contract manufacturing, 2017 - 2028 (USD Million)
  • Fig. 35 Cell and gene therapy manufacturing market for in-house manufacturing, 2017 - 2028 (USD Million)
  • Fig. 36 Cell and gene therapy manufacturing market: Workflow outlook and key takeaways
  • Fig. 37 Cell and gene therapy manufacturing market: Workflow movement analysis
  • Fig. 38 Cell and gene therapy manufacturing market for cell processing, 2017 - 2028 (USD Million)
  • Fig. 39 Cell and gene therapy manufacturing market for cell banking, 2017 - 2028 (USD Million)
  • Fig. 40 Cell and gene therapy manufacturing market for process development, 2017 - 2028 (USD Million)
  • Fig. 41 Cell and gene therapy manufacturing market for fill and finish operations, 2017 - 2028 (USD Million)
  • Fig. 42 Cell and gene therapy manufacturing market for analytical and quality testing, 2017 - 2028 (USD Million)
  • Fig. 43 Cell and gene therapy manufacturing market for raw material testing, 2017 - 2028 (USD Million)
  • Fig. 44 Cell and gene therapy manufacturing market for vector production, 2017 - 2028 (USD Million)
  • Fig. 45 Cell and gene therapy manufacturing market for others, 2017 - 2028 (USD Million)
  • Fig. 46 Cell and gene therapy manufacturing market: Regional outlook and key takeaways
  • Fig. 47 Cell and Gene therapy manufacturing market: Regional movement analysis
  • Fig. 48 North America cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 49 U.S. cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 50 Canada cell and gene therapy manufacturing) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 51 Europe cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 52 Germany cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 53 U.K. cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 54 France cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 55 Italy cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 56 Spain cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 57 Asia Pacific cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 58 Japan cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 59 China cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 60 India cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 61 South Korea cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 62 Latin America cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 63 Brazil cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 64 Mexico cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 65 Middle East & Africa cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 66 South Africa cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 67 Saudi Arabia cell and gene therapy manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 68 Strategy framework
  • Fig. 69 Market participation categorization
目次
Product Code: GVR-4-68038-289-1

Cell And Gene Therapy Manufacturing Market Growth & Trends

The global cell and gene therapy manufacturing market size is expected to reach USD 57.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 20.3% from 2021 to 2028. An exponential rise in clinical pipeline coupled with a rising number of regulatory approvals for advanced therapies has majorly driven the market.

Considering promising growth opportunities in contract development of cellular and gene-modified therapies, market participants are making focused efforts to boost their market presence. Also, bio manufacturers are signing strategic alliances with contract manufacturers to accelerate the R&D of their candidate programs. Rising demand for CMOs/CDMOs services has led to the entry of several new players as well as expansion of product development capabilities, thereby positively impacting market revenue.

Several novel methods are being introduced to advance cell and gene therapy manufacturing. For instance, the manufacturers are exploring the potential of single-use technology in production workflows. This technique is gaining increasing attention in this arena to speed the development process while reducing the overall cost and production timeline. Such technological advancements in space are anticipated to bolster market growth in the coming years.

Cell And Gene Therapy Manufacturing Market Report Highlights

The cell therapy manufacturing segment dominated the market in 2020 in terms of revenue

A high number of ongoing clinical trials of cell therapies to address the robust need for effective treatment against COVID-19 infection has resulted in segment growth

A high number of candidate molecules in the pre-commercial scale stage has contributed to the largest revenue share of the segment in 2020

On the other hand, the recent success of CAR-T therapies supplements the growth of the commercial-scale manufacturing segment

The contract manufacturing segment is expected to witness lucrative growth during the forecast period as a substantial number of bio manufacturers are turning to CMOs for efficient and rapid product development

Ongoing pandemic has accelerated the global investments in the R&D of viral vector-based vaccines, creating lucrative opportunities in the vector production segment

North America dominated the market in terms of revenue in 2020 owing to the strong research as well as a commercial base for cell and gene therapy products in the U.S.

U.S. is leading the CAR-T and gene therapy space with the highest number of approved products, thus positively influencing market growth in the region

Asia Pacific is anticipated to grow at the fastest rate throughout the forecast period

Constantly evolving viral vector production and CDMO landscapes through plant expansions and new sites are spurring the market in this region

The key players are engaged in collaboration with biopharma developers to support their product development process

Table of Content

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 Market: Cagr Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Competition Milieu
  • 2.2 Segment Outlook
  • 2.3 Market Summary, 2020 (USD Million)

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Parent Market Lineage
  • 3.3 Ancillary Market Lineage
  • 3.4 Market Dynamics
    • 3.4.1 Market Drivers Analysis
      • 3.4.1.1 Growing Pipeline Of Cell And Gene Therapy
      • 3.4.1.2 Supportive Regulatory Bodies
      • 3.4.1.3 Increase In Investment By Government And Private Players
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Technological Challenges Associated With Manufacturing
      • 3.4.2.2 High Cost Of Manufacturing
    • 3.4.3 Market Opportunity Analysis
      • 3.4.3.1 Rising Pressure On Drug Developers/Manufacturers To Meet The Growing Market Demand
      • 3.4.3.2 Expansion In Potential Markets Such As Asia Pacific And Latin America
    • 3.4.4 Market Challenge Analysis
      • 3.4.4.1 Lack Of Manufacturing Capacity
  • 3.5 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Major Deals And Strategic Alliances Analysis
    • 3.7.1 Mergers And Acquisitions
    • 3.7.2 Technological Collaborations
    • 3.7.3 Licensing And Partnerships
  • 3.8 Covid-19 Impact Analysis
    • 3.8.1 Challenge Analysis
    • 3.8.2 Opportunity Analysis
    • 3.8.3 Key Developments And Activities

Chapter 4 Competitive Analysis

  • 4.1 Recent Developments And Impact Analysis By Key Market Participants
  • 4.2 Company Mapping, By Location, Purpose, Scale Of Operation, Source Of Cell, Regulatory Compliant
  • 4.3 List Of Potential End Users
  • 4.4 List Of Emerging Players
  • 4.5 Market Differentiators
  • 4.6 Competitive Dashboard Analysis
  • 4.7 Regional Network Map

Chapter 5 Therapy Type Business Analysis

  • 5.1 Cell And Gene Therapy Manufacturing Market: Therapy Type Movement Analysis
  • 5.2 Cell Therapy Manufacturing
    • 5.2.1 Cell Therapy Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 5.2.2 Stem Cell Therapy
      • 5.2.2.1 Cell Therapy Manufacturing Market Estimates And Forecast For Stem Cell Therapy, 2017 - 2028 (USD Million)
    • 5.2.3 Non-Stem Cell Therapy
      • 5.2.3.1 Cell Therapy Manufacturing Market Estimates And Forecast For Non-Stem Cell Therapy, 2017 - 2028 (USD Million)
  • 5.3 Gene Therapy Manufacturing
    • 5.3.1 Gene Therapy Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 6 Scale Business Analysis

  • 6.1 Cell And Gene Therapy Manufacturing Market: Scale Movement Analysis
  • 6.2 Pre-Commercial/R&D Scale Manufacturing
    • 6.2.1 Cell And Gene Therapy Manufacturing market Estimates And Forecast For Pre-Commercial/R&D Scale Manufacturing, 2017 - 2028 (USD Million)
  • 6.3 Commercial Scale Manufacturing
    • 6.3.1 Cell And Gene Therapy Manufacturing market Estimates And Forecast For Commercial Scale Manufacturing, 2017 - 2028 (USD Million)

Chapter 7 Mode Business Analysis

  • 7.1 Cell And Gene Therapy Manufacturing Market: Mode Movement Analysis
  • 7.2 Contract Manufacturing
    • 7.2.1 Cell And Gene Therapy Manufacturing market For Contract Manufacturing, 2017 - 2028 (USD Million)
  • 7.3 In-House Manufacturing
    • 7.3.1 Cell And Gene Therapy Manufacturing market For In-House Manufacturing, 2017 - 2028 (USD Million)

Chapter 8 Workflow Business Analysis

  • 8.1 Cell And Gene Therapy Manufacturing Market: Workflow Movement Analysis
  • 8.2 Cell Processing
    • 8.2.1 Cell And Gene Therapy Manufacturing Market For Cell Processing, 2017 - 2028 (USD Million)
  • 8.3 Cell Banking
    • 8.3.1 Cell And Gene Therapy Manufacturing Market For Cell Banking, 2017 - 2028 (USD Million)
  • 8.4 Process Development
    • 8.4.1 Cell And Gene Therapy Manufacturing Market For Process Development, 2017 - 2028 (USD Million)
  • 8.5 Fill And Finish Operations
    • 8.5.1 Cell And Gene Therapy Manufacturing Market For Fill And Finish Operations, 2017 - 2028 (USD Million)
  • 8.6 Analytical And Quality Testing
    • 8.6.1 Cell And Gene Therapy Manufacturing Market For Analytical And Quality Testing, 2017 - 2028 (USD Million)
  • 8.7 Raw Material Testing
    • 8.7.1 Cell And Gene Therapy Manufacturing Market For Raw Material Testing, 2017 - 2028 (USD Million)
  • 8.8 Vector Production
    • 8.8.1 Cell And Gene Therapy Manufacturing Market For Vector Production, 2017 - 2028 (USD Million)
  • 8.9 Others
    • 8.9.1 Cell And Gene Therapy Manufacturing Market For Other Workflows, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Cell And Gene Therapy Manufacturing Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America Cell And Gene Therapy Manufacturing Market Estimates And Forecast,2017 - 2028 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.2.2.2 U.S. Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.2.2.3 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.2.2.4 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.2.2.5 U.S. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.2.3.2 Canada Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.2.3.3 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.2.3.4 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.2.3.5 Canada Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.3.2.2 Germany Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.3.2.3 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.3.2.4 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.3.2.5 Germany Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.3.3.2 U.K. Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.3.3.3 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.3.3.4 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.3.3.5 U.K. Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.3.4.2 France Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.3.4.3 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.3.4.4 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.3.4.5 France Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.3.5.2 Italy Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.3.5.3 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.3.5.4 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.3.5.5 Italy Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.3.6.2 Spain Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.3.6.3 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.3.6.4 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.3.6.5 Spain Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.4.2.2 Japan Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.4.2.3 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.4.2.4 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.4.2.5 Japan Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.4.3.2 China Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.4.3.3 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.4.3.4 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.4.3.5 China Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.4.4.2 India Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.4.4.3 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.4.4.4 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.4.4.5 India Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.4.5.2 South Korea Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.4.5.3 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.4.5.4 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.4.5.5 South Korea Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.5.2.2 Brazil Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.5.2.3 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.5.2.4 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.5.2.5 Brazil Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.5.3.2 Mexico Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.5.3.3 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.5.3.4 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.5.3.5 Mexico Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
  • 9.6 Middle East & Africa
    • 9.6.1 Middle East & Africa Cell And Gene Therapy Manufacturing Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.6.2.2 South Africa Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.6.2.3 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.6.2.4 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.6.2.5 South Africa Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Therapy Type, 2017 - 2028 (USD Million)
      • 9.6.3.2 Saudi Arabia Cell Therapy Manufacturing Market Estimates And Forecast, By Cell Type, 2017 - 2028 (USD Million)
      • 9.6.3.3 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Scale, 2017 - 2028 (USD Million)
      • 9.6.3.4 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Mode, 2017 - 2028 (USD Million)
      • 9.6.3.5 Saudi Arabia Cell And Gene Therapy Manufacturing Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Strategy Framework
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 Thermofisher Scientific
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Financial Performance
      • 10.3.1.3 Product Benchmarking
      • 10.3.1.4 strategic Initiatives
    • 10.3.2 MERCK KGAA.
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Milliporesigma
      • 10.3.2.3 Financial Performance
      • 10.3.2.4 Product Benchmarking
      • 10.3.2.5 Strategic Initiatives
    • 10.3.3 LONZA
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Financial Performace
      • 10.3.3.3 Product Benchmarking
      • 10.3.3.4 Strategic Initiatives
    • 10.3.4 CATALENT INC.
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Financial Performance
      • 10.3.4.3 Product Benchmarking
      • 10.3.4.4 Stretegic Initiatives
    • 10.3.5 TAKARA BIO INC.
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Financial Performance
      • 10.3.5.3 Product Benchmarking
      • 10.3.5.4 Strategic Initiatives
    • 10.3.6 F.HOFFMANN-LA ROCHE LTD
      • 10.3.6.1 Company Overview
      • 10.3.6.2 Financial Performance
      • 10.3.6.3 Product Benchmarking
      • 10.3.6.4 Strategic Initiatives
    • 10.3.7 WUXI ADVANCED THERAPIES
      • 10.3.7.1 Company Overview
      • 10.3.7.2 Financial Performance
      • 10.3.7.3 Product Benchmarking
      • 10.3.7.4 Strategic Initiatives
    • 10.3.8 SAMSUNG BIOLOGICS
      • 10.3.8.1 Company Overview
      • 10.3.8.2 Financial Performance
      • 10.3.8.3 Product Benchmarking
      • 10.3.8.4 Strategic Initiatives
    • 10.3.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 10.3.9.1 Company Overview
      • 10.3.9.2 Financial Performance
      • 10.3.9.3 Product Benchmarking
      • 10.3.9.4 Strategic Initiatives
    • 10.3.10 NOVARTIS AG
      • 10.3.10.1 Company Overview
      • 10.3.10.2 Financial Performance
      • 10.3.10.3 Product Benchmarking
      • 10.3.10.4 Strategic Initiatives
    • 10.3.11 HITACHI CHEMICAL CO LTD.
      • 10.3.11.1 Company Overview
      • 10.3.11.2 Apceth Biopharma
      • 10.3.11.3 Financial Performance
      • 10.3.11.4 Product Benchmarking
      • 10.3.11.5 Strategic Initiatives
    • 10.3.12 CELLULAR THERAPEUTICS.
      • 10.3.12.1 Company Overview
      • 10.3.12.2 Financial Performance
      • 10.3.12.3 Product Benchmarking
    • 10.3.13 MILTENYI BIOTECH.
      • 10.3.13.1 Company Overview
      • 10.3.13.2 Financial Performance
      • 10.3.13.3 Product Benchmarking
    • 10.3.13. 4strategic Initiatives
    • 10.3.14 BLUEBIRD BIO INC.
      • 10.3.14.1 Company Overview
      • 10.3.14.2 Financial Performance
      • 10.3.14.3 Product Benchmarking
      • 10.3.14.4 Strategic Initiatives